In the biotech world, risk aversion often masquerades as prudence - especially in clinical trial site selection. But in an industry where speed, cost control, and data quality determine survival, sticking to traditional trial geographieslike the U.S. and Western Europe may no longer be the “safe” route - it may bethe hidden risk that breaks your program.
The cracks are becoming harder to ignore. Growing uncertainty in U.S. regulatory timelines, the National Institutes of Health (NIH) funding cuts, and clinical site saturation have already pushed many sponsors to reconsider their domestic footprint. At the same time, the once-reliable Central and Eastern European corridor by war, forcing even large players like Roche and Merck to halt enrollment and scramble for new sites mid-trial.
Why had so many programs relied so heavily on these regions?
The answers are revealing. Eastern Europe became a powerhouse due to its combination of scientific rigor, low costs, strong investigator networks, and fast recruitment- especially in indications like neurology and oncology. Patient populations were treatment-naïve, ethnically aligned with Western regulatory expectations, and highly motivated due to gaps in local healthcare. But this over-concentration exposed a strategic flaw: single-region dependency magnifies geopolitical risk and leaves no buffer.
Yet the story in Ukraine is evolving.
Despite the challenges, Ukraine is now regaining its footing as a safe and increasingly active destination for clinical trials. Many of the major sponsors who previously suspended operations have renewed their presence, and the number of clinical trials initiated in Ukraine has started to grow again.
This resilience reflects not only local infrastructure adaptation but also the sustained commitment of experienced clinical professionals and a renewed global interest in the region’s capabilities.
Once you’ve selected the right CRO, nurturing the relationshipensures your clinical trial’s success.
Here’s how People Value Research ensures a strong, long-lasting partnership:
Clear Goal SettingFrom day one, we align with your objectives, setting benchmarks forsuccess; transparency and precision define every stage of our planning.
Proactive CommunicationRegular updates and structured meetings foster collaboration; weensure you’re always informed, with no surprises.
Performance TrackingMeasurable outcomes drive our process; we maintain alignment withyour goals by monitoring performance metrics while adapting to evolving needs.
Mutual TrustTrust is at the core of every partnership; our commitment tointegrity, quality, and client success has earned us long-standingrelationships across the healthcare sector.
The journey to clinical trial success starts with choosing the right partner; at People Value Research, we combine expertise, innovation, and collaboration to help you achieve your goals.
Our tailored solutions and dedication to excellence make us a trusted partner for clients worldwide.
Whether you’re initiating a groundbreaking study or advancing anestablished protocol, we’re here to guide you every step of the way.
Visit our
website or explore our
blog for additional insights; let’s advance the future of healthcare – together.
.png)
.svg)
.svg)
.svg)
.jpg)
